SP600125: Difference between revisions

From XenWiki
Jump to navigation Jump to search
imported>Kevin
(Created page with "==Description== MAPK/JNK inhibitor. A novel and selective inhibitor of c-Jun N-terminal kinase (JNK) SP600125 is an anthrapyrazolone inhibitor of JNK that competes with ATP t...")
(No difference)

Revision as of 07:39, 1 June 2015

Description

MAPK/JNK inhibitor.

A novel and selective inhibitor of c-Jun N-terminal kinase (JNK) SP600125 is an anthrapyrazolone inhibitor of JNK that competes with ATP to inhibit the phosphorylation of c-Jun. It prevents the activation of inflammatory genes such as COX-2, IL-2 IFN-γ and TNF-α.8,9 It prevents the activation of JNK after brain ischemia and may be effective in treatment of ischemic stroke.10

  • Sigma Description
SP600125 structure, photo from Sigma-Aldrich

Genes Affected

mapk8 mapk1

Suppliers

Usage Notes

References


>28 Xenbase articles contain a reference to SP600125 according to textpresso